Manual for the Surveillance of Vaccine-Preventable Diseases

Manual for the Surveillance of Vaccine-Preventable Diseases
4th Edition, 2008-2009

The Manual for the Surveillance of Vaccine-Preventable Diseases provides current guidelines for those directly involved in surveillance of vaccine-preventable diseases, especially personnel at the local health departments. For each of the vaccine-preventable diseases, this manual includes a chapter describing the importance of rapid case identification; the importance of surveillance; disease reduction goals; case definitions (including clinical description and case classifications); epidemiologically important data to be collected during case investigation; activities for enhancing surveillance; activities for case investigation; and activities for outbreak control. Other chapters include information on surveillance indicators; surveillance data analyses; reporting adverse events following vaccination; and enhancing surveillance. In addition, the manual includes a section reserved for insertion of state-specific guidance for VPD surveillance and extensive appendices.

List of Front Matter
Front portion of manual (PDF 269 KB)
Cover, spine, title pages (titles and acknowledgements), acronyms, definition of terms, table of contents, introduction, etc.


List of Chapters
The first link goes directly to the chapter's web page. However, most will want to print these chapters using the second link (PDF) which opens in Adobe Reader.

Chapter 1: Diphtheria (PDF 359 KB)
Chapter 2: Haemophilus influenzae type b (PDF 366 KB)
Chapter 3: Hepatitis A (PDF 321 KB)
Chapter 4: Hepatitis B (PDF 413 KB)
Chapter 5: Human Papillomavirus (PDF 366 KB)
Chapter 6: Influenza (PDF 283 KB) Updated Apr 2009
Chapter 7: Measles (PDF 531 KB) Updated Apr 2009
Chapter 8: Meningococcal (PDF 350 KB)
Chapter 9: Mumps (PDF 407 KB) Updated Apr 12, 2010
http://www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.htm

Note: Guidance related to the duration of time that mumps patients should be isolated following onset of symptoms has changed. Consult the MMWR: Updated Recommendations for Isolation of Persons with Mumps. This MMWR supersedes the outdated information found in Chapter 9: Mumps in Section XIII - Outbreak Control. (Oct 2008)

Chapter 10: Pertussis (PDF 458 KB) Updated Aug 2009
Chapter 11: Pneumococcal (PDF 431 KB)
Chapter 12: Polio (PDF 97 KB) Note: This chapter is not yet available.
Meanwhile, please consult last edition's Polio Chapter.
Chapter 13: Rotavirus (PDF 430 KB)
Chapter 14: Rubella (PDF 434 KB)
Chapter 15: Congenital Rubella Syndrome (PDF 366 KB)
Chapter 16: Tetanus (PDF 407 KB)
Chapter 17: Varicella (PDF 508 KB)
Chapter 18: Surveillance Indicators (PDF 324 KB)
Chapter 19: Enhancing Surveillance (PDF 292 KB)
Chapter 20: Analysis of Surveillance Data (PDF 357 KB)
Chapter 21: Surveillance for Adverse Events Following Vaccination (PDF 417 KB)
Chapter 22: Laboratory Support for the Surveillance of Vaccine-Preventable Diseases (PDF 749 KB)
Chapter 23: National Surveillance of Vaccine-Preventable Diseases (PDF 294 KB)
Chapter 24: State-Specific Surveillance of Vaccine-Preventable Diseases (PDF 140 KB)

open here to find all the chapters and List of Appendices:
http://www.cdc.gov/vaccines/pubs/surv-manual/default.htm